Several other research firms have also weighed in on EVHC. Cantor Fitzgerald restated a buy rating on shares of Envision Healthcare Corporation in a research note on Monday, July 24th. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a strong sell rating to a buy rating and set a $70.00 price objective on the stock in a research note on Tuesday, July 4th. BidaskClub lowered shares of Envision Healthcare Corporation from a hold rating to a sell rating in a research note on Tuesday, August 1st. Mizuho lowered their price objective on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a neutral rating on the stock in a research note on Wednesday, August 9th. Finally, Bank of America Corporation lowered their price objective on shares of Envision Healthcare Corporation from $72.00 to $60.00 and set a buy rating on the stock in a research note on Monday, October 9th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of Buy and an average price target of $51.71.
Envision Healthcare Corporation (NYSE:EVHC) last released its quarterly earnings data on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.08). The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.86% and a negative net margin of 6.39%. The firm’s revenue for the quarter was up 142.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.13 earnings per share.
TRADEMARK VIOLATION NOTICE: This news story was reported by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.com-unik.info/2017/11/02/envision-healthcare-corporation-evhc-given-a-71-00-price-target-at-jefferies-group-llc.html.
Envision Healthcare Corporation announced that its board has initiated a share buyback plan on Monday, September 18th that allows the company to repurchase $250.00 million in shares. This repurchase authorization allows the company to buy up to 4.5% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Oregon Public Employees Retirement Fund boosted its holdings in Envision Healthcare Corporation by 114.3% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 26,353 shares of the company’s stock valued at $1,185,000 after purchasing an additional 14,053 shares during the period. Prudential Financial Inc. boosted its holdings in Envision Healthcare Corporation by 1.2% in the 3rd quarter. Prudential Financial Inc. now owns 161,605 shares of the company’s stock valued at $7,264,000 after purchasing an additional 1,950 shares during the period. American Century Companies Inc. boosted its holdings in Envision Healthcare Corporation by 97.4% in the 3rd quarter. American Century Companies Inc. now owns 1,003,310 shares of the company’s stock valued at $45,099,000 after purchasing an additional 494,923 shares during the period. Gabelli Funds LLC boosted its holdings in Envision Healthcare Corporation by 8.3% in the 3rd quarter. Gabelli Funds LLC now owns 333,000 shares of the company’s stock valued at $14,968,000 after purchasing an additional 25,500 shares during the period. Finally, Gamco Investors INC. ET AL boosted its holdings in Envision Healthcare Corporation by 56.4% in the 3rd quarter. Gamco Investors INC. ET AL now owns 53,197 shares of the company’s stock valued at $2,391,000 after purchasing an additional 19,180 shares during the period.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
What are top analysts saying about Envision Healthcare Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Corporation and related companies.